Mary Beth Fritz - Feb 8, 2024 Form 4 Insider Report for Prestige Consumer Healthcare Inc. (PBH)

Signature
/s/ Mary Beth Fritz by William P'Pool attorney-in-fact pursuant to power of attorney dated August 7, 2018 on file with the Commission
Stock symbol
PBH
Transactions as of
Feb 8, 2024
Transactions value $
-$68,781
Form type
4
Date filed
2/12/2024, 12:08 PM
Previous filing
Sep 15, 2023
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBH Common Stock, par value $0.01 per share Options Exercise $299K +5.34K +33.49% $56.11 21.3K Feb 8, 2024 Direct
transaction PBH Common Stock, par value $0.01 per share Sale -$368K -5.34K -25.09% $69.00 15.9K Feb 8, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBH Employee Stock Options (right to buy) Options Exercise $0 -5.34K -100% $0.00* 0 Feb 8, 2024 Common Stock 5.34K $56.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $65.71 to $69.00.
F2 The options vested in three installments on 1,778 shares on May 8, 2018 and 1,779 shares each on May 8, 2019 and May 8, 2020.